Recently added articles from Biotech Equipment Update:

SIEMENS HEALTHCARE DEBUTS CARDIOVASCULR SOLUTIONS.

May 01, 2008 ... Siemens Healthcare demonstrated how its laboratory diagnostics, imaging and information technology (IT) solutions are helping to "Bring a New Rhythm to Cardiology Workflow," at the 57th Annual Scientific Session of the American College of Cardiology (ACC). Siemens showcased the ...

ATRIAL FIBRILLATION PROCEDURES TO GROW OVER 25% ANNUALLLY.

May 01, 2008 ... According to Millennium Research Group's Global Markets for Atrial Fibrillation (AF) Treatment Devices 2008 report, over 32,000 electrophysiology (EP) procedures were performed for the treatment of AF in the US in 2007. AF EP procedure volumes will increase at a compound annual growth rate ...

ALSIUS GETS MARKET APPROVAL IN CANADA/MEXICO FOR IVTM.

May 01, 2008 ... Alsius Corporation (NASDAQ:ALUS), Irvine, Calif., the worldwide leader in intravascular patient temperature management therapies, has received approval from regulatory authorities in China and Mexico to market its intravascular temperature management (IVTM(TM)) systems and catheters in ...

MEDTRONIC'S NEW ENDEAVOR STENT APPROVED IN CANADA.

May 01, 2008 ... Medtronic of Canada Ltd. has received regulatory approval from Health Canada's Therapeutic Products Directorate (TPD) for use of the Endeavor drug-eluting coronary stent (DES) system in the treatment of coronary artery disease. The company expects to begin commercial sales of the Endeavor ...

VALOR UNVEILS FIRST HUMAN IMPLANT OF NEUCRYLATE AN.

May 01, 2008 ... Valor Medical, San Diego, Calif., an emerging medical device company in San Diego, CA, has announced that the first human implant of Neucrylate AN for treatment of cerebral aneurysms was performed by Dr. Sean Pakbaz at the University of Tehran. The treatment was under the guidance of a ...